Chamber of Commerce Study Weighs in On HHS’s International Pricing Index Model PolicyAllbiopro2019-08-01T10:49:24+09:008월 1st, 2019|
Alexandria Real Estate Equities Plans Another Boston Life Sciences Lab FacilityAllbiopro2019-08-01T10:48:55+09:008월 1st, 2019|
Merck’s Keytruda Has Been Approved for 20+ Indications, With the Latest Being for Esophageal CancerAllbiopro2019-08-01T10:48:25+09:008월 1st, 2019|
Charles River Labs to Launch Bay Area CRADL Facility in 2020Allbiopro2019-08-01T10:47:51+09:008월 1st, 2019|
HHS Announces Possible Roadmap for Importing Drugs from CanadaAllbiopro2019-08-01T10:47:18+09:008월 1st, 2019|
Results of the Pivotal Phase 3 Study of the Bempedoic Acid / Ezetimibe Combination Tablet Published in the European Journal of Preventative Cardiology Demonstrated Significant LDL-C LoweringAllbiopro2019-08-01T10:46:49+09:008월 1st, 2019|
Music to the ear? Podcasts, streaming radio create new opportunities for pharma, experts sayAllbiopro2019-08-01T10:45:36+09:008월 1st, 2019|
Megadeals aside, pharma M&A actually dropped in the first half of 2019: reportAllbiopro2019-08-01T10:45:05+09:008월 1st, 2019|
Mylan, which bought Novartis CF drugs, circles back for the manufacturing assetsAllbiopro2019-08-01T10:44:33+09:008월 1st, 2019|
Roche extends $4.3B Spark tender offer yet again. What are watchdogs so worried about?Allbiopro2019-08-01T10:44:02+09:008월 1st, 2019|
Would Trump’s new drug-imports plan do much to prices—or to pharma?Allbiopro2019-08-01T10:43:29+09:008월 1st, 2019|
Amarin CEO: When it comes to Vascepa expansion, ‘we can do this on our own’Allbiopro2019-08-01T10:42:56+09:008월 1st, 2019|
Chasing Pfizer and J&J, Bayer’s Nubeqa nabs fast FDA nod in prostate cancerAllbiopro2019-08-01T10:42:22+09:008월 1st, 2019|
Deal-minded Pfizer checked out Mylan’s price-fixing probe, report says. Upshot? No red flagsAllbiopro2019-08-01T10:41:47+09:008월 1st, 2019|
Congress hits panic button over potential Chinese heparin shortage as swine herds ravaged by disease Allbiopro2019-08-01T10:41:17+09:008월 1st, 2019|
Wellington raises €210M fund to back European biotechsAllbiopro2019-08-01T10:40:43+09:008월 1st, 2019|